<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Metab Disord</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Metab Disord</journal-id><journal-title-group><journal-title>Journal of Diabetes and Metabolic Disorders</journal-title></journal-title-group><issn pub-type="epub">2251-6581</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26413493</article-id><article-id pub-id-type="pmc">4583053</article-id><article-id pub-id-type="publisher-id">s40200-014-0081-6</article-id><article-id pub-id-type="doi">10.1186/s40200-014-0081-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Zahedi</surname><given-names>Hoda</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hoda.s.zahedi@gmail.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Eghtesadi</surname><given-names>Shahryar</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>egtesadi@yahoo.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Seifirad</surname><given-names>Soroush</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sseifirad@gmail.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Rezaee</surname><given-names>Neshat</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>neshat_hilar83@yahoo.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Shidfar</surname><given-names>Farzad</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>f-shidfar@tums.ac.ir</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Heydari</surname><given-names>Iraj</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>irajheydari@gmail.com</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Golestan</surname><given-names>Banafsheh</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>bgolestan@sina.tums.ac</email></contrib><contrib contrib-type="author" corresp="yes" id="A8"><name><surname>Jazayeri</surname><given-names>Shima</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>sh_jaz@yahoo.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="I2"><label>2</label>Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran</aff><aff id="I3"><label>3</label>Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="I4"><label>4</label>Institute of Endocrinology and Metabolism, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran</aff><aff id="I5"><label>5</label>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>25</day><month>7</month><year>2014</year></pub-date><volume>13</volume><fpage>81</fpage><lpage>81</lpage><history><date date-type="received"><day>7</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>13</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Zahedi et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Zahedi et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.jdmdonline.com/content/13/1/81"/><abstract><sec><title>Background</title><p>Low grade inflammation and oxidative stress are the key factors in the pathogenesis and development of diabetes and its complications. Coenzyme Q10 (CoQ10) is known as an antioxidant and has a vital role in generation of cellular energy providing. This study was undertaken to evaluate the effects of CoQ10 supplementation on lipid profiles and glycemic controls in patients with diabetes.</p></sec><sec><title>Methods</title><p>Fifty patients with diabetes were randomly allocated into two groups to receive either 150&#x000a0;mg CoQ10 or placebo daily for 12&#x000a0;weeks. Before and after supplementation, fasting venous blood samples were collected and lipid profiles containing triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) and glycemic indices comprising of fasting plasma glucose (FPG), insulin and hemoglobin A<sub>1</sub>C (HbA<sub>1</sub>C) were measured. Insulin resistance was calculated using HOMA-IR index.</p></sec><sec><title>Results</title><p>Forty patients completed the study. After intervention FPG and HbA<sub>1</sub>C were significantly lower in the CoQ10 group compared to the placebo group, but there were no significant differences in serum insulin and HOMA-IR between the two groups. Although total cholesterol did not change in the Q10 group after supplementation, triglyceride and HDL-C significantly decreased and LDL-C significantly increased in the CoQ10 group.</p></sec><sec><title>Conclusion</title><p>The present study showed that treatment with Q10 may improve glycemic control with no favorable effects on lipid profiles in type 2 patients with diabetes.</p></sec><sec><title>Trial registration</title><p>IRCT registry number: <ext-link ext-link-type="uri" xlink:href="IRCT138806102394N1">IRCT138806102394N1</ext-link></p></sec></abstract><kwd-group><kwd>Coenzyme Q10</kwd><kwd>Diabetes mellitus type 2</kwd><kwd>Blood glucose</kwd><kwd>Oxidative stress</kwd><kwd>Inflammation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Beyond certain medical treatments, food diets and supplementation plays a key role in the management of chronic diseases and promoting health status of human beings in the 21th century [<xref ref-type="bibr" rid="B1">1</xref>]. Previous studies have shown that the dysfunction of endothelium caused by oxidative stress [<xref ref-type="bibr" rid="B2">2</xref>] and inflammation [<xref ref-type="bibr" rid="B3">3</xref>] resulted from hyperglycemia is the key factor in the incidence and development of vascular complications of diabetes; Hence antioxidants intake is an appropriate intervention to improve this condition [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>Coenzyme Q10 (CoQ10), a kind of benzoquinone, also known as ubiquinone, is a vitamin like antioxidant that can be synthesized in the body and is found in all biologic membranes [<xref ref-type="bibr" rid="B5">5</xref>],[<xref ref-type="bibr" rid="B6">6</xref>]. Also it is a vital component of the mitochondrial electron transport chain that has an intermittent role in ATP production [<xref ref-type="bibr" rid="B2">2</xref>]. Moreover, this ubiquinone may cause regeneration of reduced forms of vitamin E and C [<xref ref-type="bibr" rid="B4">4</xref>] and it shows stronger antioxidant properties than vitamin E [<xref ref-type="bibr" rid="B2">2</xref>]. In addition, CoQ10 can protect the lipids of membranes and blood circulation against peroxidation [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Research investment toward discovering appropriate supplements in complementary medicine has a high importance for optimal management of patient with diabetes [<xref ref-type="bibr" rid="B8">8</xref>]. Studies have shown that amongst the clinical supported supplements, Q10 supplements are one of the most popular ones that might be valuable in the management of neurodegenerative and cardiovascular diseases [<xref ref-type="bibr" rid="B5">5</xref>],[<xref ref-type="bibr" rid="B7">7</xref>],[<xref ref-type="bibr" rid="B9">9</xref>]-[<xref ref-type="bibr" rid="B11">11</xref>].</p><p>The importance of this supplementation in inherited diabetes is well known [<xref ref-type="bibr" rid="B12">12</xref>]-[<xref ref-type="bibr" rid="B14">14</xref>]. It has been shown that the serum concentrations of Coenzyme Q10 are reduced in patient with diabetes [<xref ref-type="bibr" rid="B15">15</xref>]. Regarding the benefits of Q10 supplementation shown in animal studies [<xref ref-type="bibr" rid="B3">3</xref>],[<xref ref-type="bibr" rid="B16">16</xref>]-[<xref ref-type="bibr" rid="B18">18</xref>] and controversial findings of human trials [<xref ref-type="bibr" rid="B4">4</xref>],[<xref ref-type="bibr" rid="B19">19</xref>]-[<xref ref-type="bibr" rid="B21">21</xref>], this study was conducted to evaluate the effects of Q10 supplementation on lipid profiles and glycemic control in type 2 patients with diabetes.</p></sec><sec><title>Methods and material</title><p>In a double blind randomized controlled trial, fifty patients with diabetes, aged less than 75&#x000a0;years were randomly allocated into two groups. They received either 150&#x000a0;mg CoQ10 supplement (Natural Factors Inc. Canada) or 150&#x000a0;mg placebo (maize starch) in three divided 50&#x000a0;mg doses daily for 12&#x000a0;weeks. The inclusion criteria were as follows: diagnosis of type 2 diabetes which were defined as fasting plasma glucose (FPG) &#x02265;126&#x000a0;mg/dl or 2&#x000a0;hours plasma glucose (2HPG) &#x02265;200&#x000a0;mg/dl), having diabetes for at least one year, Hemoglobin A1C (HbA1C) &#x0003c;9%, serum concentration of triglyceride less than 400&#x000a0;mg/dl. Exclusion criteria were body mass index (BMI) more than 40 Kg/m<sup>2</sup>, history of myocardial infarction or stroke, insulin therapy, incidence of diseases (such as liver, renal or thyroid disorders), consumption of antioxidant supplements in the past two months, Warfarin intake, uncontrolled hypertension and pregnancy or lactation. The patients who consumed less than 70% of supplements were also excluded from the study.</p><p>Venous blood samples (10&#x000a0;ml) were collected between 8&#x02013;9 A.M. after fasting for 10&#x02013;12 hours at baseline and after 12&#x000a0;weeks of supplementation with CoQ10. The measurements were performed on frozen serum samples. The serum levels of Q10 were measured before and after intervention using high-pressure liquid chromatography (HPLC) method and an Immunodiagnostik kit (Immunodiagnostik/Bensheim, Germany). The serum levels of triglyceride were measured using GOP-PAP method and a Pars Azmoon kit (Pars Azmoon Inc.,Tehran, Iran). Total cholesterol was tested using the same kit through Liasys auto analyzer device (Liasys, Roma, Italy). Serum high density lipoprotein cholesterol (HDL-C) levels also were determined using sedimentary method with the same kit. Low density lipoprotein cholesterol (LDL-C) levels were calculated indirectly using Friedewald Equation:<disp-formula id="bmcM1"><label>(1)</label><mml:math id="M1" name="s40200-014-0081-6-i1" overflow="scroll"><mml:mi mathvariant="normal">LDL</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">C</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">C</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">HDL</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant="normal">C</mml:mi><mml:mo>&#x02010;</mml:mo><mml:mi mathvariant="normal">TG</mml:mi><mml:mspace width="0.25em"/><mml:mo stretchy="true">/</mml:mo><mml:mspace width="0.25em"/><mml:mn>5</mml:mn></mml:math></disp-formula></p><p>Glycemic control indices included FPG, homeostatic model assessment (HOMA-IR) and HbA<sub>1</sub>C. FPG was measured using glucose oxidase method (Pars Azmoon Inc., Tehran, Iran). Insulin levels were measured using RIA method and Immonotech kit. HOMA-IR was calculated using following formula:<disp-formula id="bmcM2"><label>(2)</label><mml:math id="M2" name="s40200-014-0081-6-i2" overflow="scroll"><mml:mi mathvariant="italic">HOMA</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="italic">IR</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">Insulin</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="italic">&#x003bc;m</mml:mi><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="italic">ml</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="italic">Glu</mml:mi><mml:mo>cos</mml:mo><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="italic">mg</mml:mi><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="italic">dl</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mn>405</mml:mn></mml:mfrac></mml:math></disp-formula></p><p>HbA<sub>1</sub>C was determined using chromatography method by DS5 Drew Scientific machine (ion exchange chromatography).</p><p>Dietary intakes were assessed using 24-hour dietary recall questionnaires before and after intervention. Energy and nutrient intakes were calculated by Nutritionist&#x02011;IV software (First Data Bank, The Hearst Corporation, San Bruno, CA).</p><p>The statistical tests were conducted by paired sample t-test, independent sample t-test and ANCOVA using the statistical package for the social sciences (SPSS), version 15; (SPSS; Inc., Chicago, IL, USA). Kolmogorov&#x02013;Smirnov test was used to evaluate normality. Due to normal distribution pattern of our data, parametric studies were applied for statistical analysis. Data were presented as means and standard deviations. P&#x02009;&#x0003c;&#x02009;0.05 was considered as statistically significant. Ethical approval was obtained from the Medical Ethics Committee of Iran University of Medical Sciences and the participants signed the informed consent.</p></sec><sec sec-type="results"><title>Results</title><p>Forty patients completed the 12&#x000a0;weeks study protocol. Ten patients were excluded from the study. Four patients lost to follow up and six patients consumed less than 70% of the given supplements.</p><p>Baseline characteristics and nutrients intakes of participants are shown in Tables&#x000a0;<xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>. No statistically significant differences were observed between the two groups with regard to characteristics and nutrients intakes at baseline.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline characteristics of participants</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr valign="top"><th align="left" valign="top"><bold>Variables</bold></th><th align="left" valign="top">&#x000a0;</th><th align="left" valign="top"><bold>Q</bold><sub>
<bold>10</bold>
</sub><bold>(n&#x02009;=&#x02009;20)</bold></th><th align="left" valign="top"><bold>Placeo (n&#x02009;=&#x02009;20)</bold></th><th align="left" valign="top"><bold>P-value</bold></th></tr></thead><tbody><tr valign="top"><td colspan="2" align="left" valign="top">Age (years)</td><td align="left" valign="top">53.5&#x02009;&#x000b1;&#x02009;9.7</td><td align="left" valign="top">58.8&#x02009;&#x000b1;&#x02009;9.6</td><td align="left" valign="top">NS*</td></tr><tr valign="top"><td colspan="2" align="left" valign="top">Diabetes duration (years)</td><td align="left" valign="top">7.4&#x02009;&#x000b1;&#x02009;5.2</td><td align="left" valign="top">7.9&#x02009;&#x000b1;&#x02009;6.7</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td rowspan="2" align="left" valign="top">Sex</td><td align="left" valign="top">Female</td><td align="left" valign="top">9</td><td align="left" valign="top">12</td><td rowspan="2" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Male</td><td align="left" valign="top">11</td><td align="left" valign="top">8</td></tr><tr valign="top"><td rowspan="2" align="left" valign="top">Smoking</td><td align="left" valign="top">Yes</td><td align="left" valign="top">2</td><td align="left" valign="top">2</td><td rowspan="2" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">No</td><td align="left" valign="top">18</td><td align="left" valign="top">18</td></tr><tr valign="top"><td rowspan="7" align="left" valign="top">Family history diabetes hypertension cardiovascular</td><td colspan="4" align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td align="left" valign="top">Yes</td><td align="left" valign="top">14</td><td align="left" valign="top">9</td><td rowspan="2" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">No</td><td align="left" valign="top">6</td><td align="left" valign="top">11</td></tr><tr valign="top"><td align="left" valign="top">Yes</td><td align="left" valign="top">13</td><td align="left" valign="top">10</td><td rowspan="2" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">No</td><td align="left" valign="top">7</td><td align="left" valign="top">10</td></tr><tr valign="top"><td align="left" valign="top">Yes</td><td align="left" valign="top">7</td><td align="left" valign="top">10</td><td rowspan="2" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">No</td><td align="left" valign="top">13</td><td align="left" valign="top">10</td></tr><tr valign="top"><td rowspan="4" align="left" valign="top">Kind of drug used</td><td align="left" valign="top">Hypoglycemic</td><td align="left" valign="top">4</td><td align="left" valign="top">4</td><td rowspan="4" align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Hypolipidemic</td><td align="left" valign="top">7</td><td align="left" valign="top">7</td></tr><tr valign="top"><td align="left" valign="top">Antihypertensive</td><td align="left" valign="top">1</td><td align="left" valign="top">1</td></tr><tr valign="top"><td align="left" valign="top">Combined</td><td align="left" valign="top">8</td><td align="left" valign="top">8</td></tr><tr valign="top"><td align="left" valign="top">Serum levels of Q10 (nmol/L)</td><td align="left" valign="top">&#x000a0;</td><td align="left" valign="top">1.44&#x02009;&#x000b1;&#x02009;0.15</td><td align="left" valign="top">1.40&#x02009;&#x000b1;&#x02009;0.18</td><td align="left" valign="top">NS</td></tr></tbody></table><table-wrap-foot><p>*NS: Not Significant.</p><p>P&#x02009;&#x0003c;&#x02009;0.05 is considered as significant.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Nutrient intake based on 24&#x000a0;hour dietary recall</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr valign="top"><th align="left" valign="top"><bold>Variables</bold></th><th align="left" valign="top"><bold>Before intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>After intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>P-value</bold></th></tr></thead><tbody><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Energy (Kcal)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">1466.3&#x02009;&#x000b1;&#x02009;626.3</td><td align="left" valign="top">1505.8&#x02009;&#x000b1;&#x02009;319.8</td><td align="left" valign="top">NS<sup>(c)</sup></td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">1461.3&#x02009;&#x000b1;&#x02009;407.1</td><td align="left" valign="top">1443.1&#x02009;&#x000b1;&#x02009;340.0</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS<sup>*(a)</sup></td><td align="left" valign="top">NS<sup>(b)</sup></td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Carbohydrate (g)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">220.6&#x02009;&#x000b1;&#x02009;119.7</td><td align="left" valign="top">214.9&#x02009;&#x000b1;&#x02009;59.4</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">212.2&#x02009;&#x000b1;&#x02009;68.0</td><td align="left" valign="top">223.9&#x02009;&#x000b1;&#x02009;78.0</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Protein (g)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">92.8&#x02009;&#x000b1;&#x02009;127.8</td><td align="left" valign="top">86.1&#x02009;&#x000b1;&#x02009;27.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">68.0&#x02009;&#x000b1;&#x02009;36.0</td><td align="left" valign="top">58.3&#x02009;&#x000b1;&#x02009;19.7</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Fat (g)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">78.5&#x02009;&#x000b1;&#x02009;18.1</td><td align="left" valign="top">41.6&#x02009;&#x000b1;&#x02009;19.5</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">39.1&#x02009;&#x000b1;&#x02009;22.1</td><td align="left" valign="top">39.1&#x02009;&#x000b1;&#x02009;13.8</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Fiber (g)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">13.1&#x02009;&#x000b1;&#x02009;6.3</td><td align="left" valign="top">14.6&#x02009;&#x000b1;&#x02009;2.8</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">13.1&#x02009;&#x000b1;&#x02009;7.0</td><td align="left" valign="top">14.5&#x02009;&#x000b1;&#x02009;10.1</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Cholesterol (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">305.9&#x02009;&#x000b1;&#x02009;750.3</td><td align="left" valign="top">149.8&#x02009;&#x000b1;&#x02009;92.2</td><td align="left" valign="top">NS<sup>(c)</sup></td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">328.1&#x02009;&#x000b1;&#x02009;504.1</td><td align="left" valign="top">134.7&#x02009;&#x000b1;&#x02009;59.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS<sup>*(a)</sup></td><td align="left" valign="top">NS<sup>(b)</sup></td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Vitamin E (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">73.3&#x02009;&#x000b1;&#x02009;58.6</td><td align="left" valign="top">103.9&#x02009;&#x000b1;&#x02009;123.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">75.1&#x02009;&#x000b1;&#x02009;52.5</td><td align="left" valign="top">103.1&#x02009;&#x000b1;&#x02009;147.0</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Vitamin C (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">4.6&#x02009;&#x000b1;&#x02009;3.1</td><td align="left" valign="top">4.3&#x02009;&#x000b1;&#x02009;3.1</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">2.9&#x02009;&#x000b1;&#x02009;1.9</td><td align="left" valign="top">2.7&#x02009;&#x000b1;&#x02009;1.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Vitamin A (RE)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">718.3&#x02009;&#x000b1;&#x02009;1170.8</td><td align="left" valign="top">685.7&#x02009;&#x000b1;&#x02009;1407.6</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">2687.2&#x02009;&#x000b1;&#x02009;7787.3</td><td align="left" valign="top">557.5&#x02009;&#x000b1;&#x02009;525.8</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Riboflavin (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">2.8&#x02009;&#x000b1;&#x02009;7.1</td><td align="left" valign="top">1.2&#x02009;&#x000b1;&#x02009;0.6</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">2.3&#x02009;&#x000b1;&#x02009;4.5</td><td align="left" valign="top">1.3&#x02009;&#x000b1;&#x02009;0.6</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td align="left" valign="top"><bold>Variables</bold></td><td align="left" valign="top"><bold>Before intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></td><td align="left" valign="top"><bold>After intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></td><td align="left" valign="top"><bold>P-value</bold></td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Zinc (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">11.8&#x02009;&#x000b1;&#x02009;24.1</td><td align="left" valign="top">6.3&#x02009;&#x000b1;&#x02009;2.6</td><td align="left" valign="top">NS<sup>(c)</sup></td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">7.9&#x02009;&#x000b1;&#x02009;6.5</td><td align="left" valign="top">5.8&#x02009;&#x000b1;&#x02009;2.5</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS<sup>*(a)</sup></td><td align="left" valign="top">NS<sup>(b)</sup></td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Selenium (mg)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">0.09&#x02009;&#x000b1;&#x02009;0.07</td><td align="left" valign="top">0.07&#x02009;&#x000b1;&#x02009;0.04</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">0.08&#x02009;&#x000b1;&#x02009;0.04</td><td align="left" valign="top">0.08&#x02009;&#x000b1;&#x02009;0.04</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p><bold>*</bold>NS: Not Significant.</p><p>P&#x02009;&#x0003c;&#x02009;0.05 is considered as significant.</p><p><sup>(a)</sup>Based on independent t-test.</p><p><sup>(b)</sup>Based on ANCOVA adjusted for baseline values.</p><p><sup>(c)</sup>Based on paired t-test.</p></table-wrap-foot></table-wrap><p>The serum levels of Q10 had no statistical significant differences between two groups before intervention but these levels were significantly higher in Q10 group (P&#x02009;&#x0003c;&#x02009;0.05) after 12&#x000a0;weeks without significant change in the placebo group (P&#x02009;&#x0003e;&#x02009;0.05).</p><p>There were no significant differences in the baseline values of lipid profile variables between the two groups (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). Serum levels of triglyceride and HDL-C had no significant differences between the two groups at the end of the study, but LDL-C and total cholesterol were significantly higher in the Q10 group compared to the placebo group. Although LDL-C significantly increased after 12&#x000a0;weeks of supplementation with Q10, triglyceride and HDL-C decreased after intervention.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Lipid profile indices before and after intervention</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr valign="top"><th align="left" valign="top"><bold>Variable</bold></th><th align="left" valign="top"><bold>Before intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>After intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>P-value</bold></th></tr></thead><tbody><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Triglyceride (mg/dl)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">136.90&#x02009;&#x000b1;&#x02009;53.1</td><td align="left" valign="top">113.10&#x02009;&#x000b1;&#x02009;50.3</td><td align="left" valign="top">0.004<sup>(c)</sup></td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">146.25&#x02009;&#x000b1;&#x02009;65.5</td><td align="left" valign="top">139.85&#x02009;&#x000b1;&#x02009;64.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS<sup>*(a)</sup></td><td align="left" valign="top">NS<sup>(b)</sup></td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Total cholesterol (mg/dl)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">143.05&#x02009;&#x000b1;&#x02009;16.4</td><td align="left" valign="top">151.15&#x02009;&#x000b1;&#x02009;24.8</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">145.90&#x02009;&#x000b1;&#x02009;23.5</td><td align="left" valign="top">138.15&#x02009;&#x000b1;&#x02009;23.3</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">0.02</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>LDL-C (mg/dl)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">74.55&#x02009;&#x000b1;&#x02009;15.3</td><td align="left" valign="top">90.65&#x02009;&#x000b1;&#x02009;18.7</td><td align="left" valign="top">0.001</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">76.40&#x02009;&#x000b1;&#x02009;21.6</td><td align="left" valign="top">71.15&#x02009;&#x000b1;&#x02009;20.3</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x0003c;0.001</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>HDL-C (mg/dl)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">42.40&#x02009;&#x000b1;&#x02009;8.7</td><td align="left" valign="top">37.15&#x02009;&#x000b1;&#x02009;10.7</td><td align="left" valign="top">0.002</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">40.25&#x02009;&#x000b1;&#x02009;10.5</td><td align="left" valign="top">38.85&#x02009;&#x000b1;&#x02009;10.4</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p><bold>*</bold>NS: Not Significant.</p><p>P&#x02009;&#x0003c;&#x02009;0.05 is considered as significant.</p><p><sup>(a)</sup>Based on independent t-test.</p><p><sup>(b)</sup>Based on ANCOVA adjusted for baseline values.</p><p><sup>(c)</sup>Based on paired t-test.</p><p>CoQ10: Coenzyme Q10; LDL-C: Low-Density Lipoprotein Cholesterol; HDL: High-Density Lipoprotein Cholesterol.</p></table-wrap-foot></table-wrap><p>The results of glycemic control are shown in Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>. After intervention FPG and HbA<sub>1</sub>C were significantly lower in the CoQ10 group compared to the placebo group, but there were no significant differences in serum insulin and HOMA-IR between the two groups. Moreover, there were no significant changes in glycemic control indices after supplementation with Q10.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Glycemic control indices before and after intervention</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr valign="top"><th align="left" valign="top"><bold>Variable</bold></th><th align="left" valign="top"><bold>Before intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>After intervention (Mean&#x02009;&#x000b1;&#x02009;SD)</bold></th><th align="left" valign="top"><bold>P-value</bold></th></tr></thead><tbody><tr valign="top"><td colspan="4" align="left" valign="top"><bold>FPG (mg/dl)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">131.45&#x02009;&#x000b1;&#x02009;36.3</td><td align="left" valign="top">115.95&#x02009;&#x000b1;&#x02009;20.7</td><td align="left" valign="top">NS<sup>(c)</sup></td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">132.75&#x02009;&#x000b1;&#x02009;38.2</td><td align="left" valign="top">152.55&#x02009;&#x000b1;&#x02009;65.2</td><td align="left" valign="top">0.03</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS<sup>*(a)</sup></td><td align="left" valign="top">0.02<sup>(b)</sup></td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>Insulin (&#x003bc;m/ml)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">9.23&#x02009;&#x000b1;&#x02009;6.6</td><td align="left" valign="top">8.58&#x02009;&#x000b1;&#x02009;6.6</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">11.02&#x02009;&#x000b1;&#x02009;4.8</td><td align="left" valign="top">10.80&#x02009;&#x000b1;&#x02009;5.5</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>HOMA-IR</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">3.14&#x02009;&#x000b1;&#x02009;2.9</td><td align="left" valign="top">2.59&#x02009;&#x000b1;&#x02009;2.4</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">3.61&#x02009;&#x000b1;&#x02009;1.9</td><td align="left" valign="top">4.44&#x02009;&#x000b1;&#x02009;4.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">NS</td><td align="left" valign="top">&#x000a0;</td></tr><tr valign="top"><td colspan="4" align="left" valign="top"><bold>HbA</bold><sub>
<bold>1</bold>
</sub><bold>C (%)</bold></td></tr><tr valign="top"><td align="left" valign="top">Q10 (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">6.83&#x02009;&#x000b1;&#x02009;0.8</td><td align="left" valign="top">6.44&#x02009;&#x000b1;&#x02009;0.9</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">Placebo (n&#x02009;=&#x02009;20)</td><td align="left" valign="top">6.95&#x02009;&#x000b1;&#x02009;1.1</td><td align="left" valign="top">7.18&#x02009;&#x000b1;&#x02009;1.1</td><td align="left" valign="top">NS</td></tr><tr valign="top"><td align="left" valign="top">P-value</td><td align="left" valign="top">NS</td><td align="left" valign="top">0.01</td><td align="left" valign="top">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p><bold>*</bold>NS: Not Significant.</p><p>P&#x02009;&#x0003c;&#x02009;0.05 is considered as significant.</p><p><sup>(a)</sup>Based on independent t-test.</p><p><sup>(b)</sup>Based on ANCOVA adjusted for baseline values.</p><p><sup>(c)</sup>Based on paired t-test.</p><p>CoQ10: Coenzyme Q10; FPG: Fasting Plasma Glucose; HOMA-IR: Homeostatic Model Assessment; HbA<sub>1</sub>C: Hemoglobin A<sub>1</sub>C.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>The aim of the present study was to investigate the effects of 12&#x000a0;weeks CoQ10 supplementation on the lipid profile and glycemic determinants in patients with diabetes. According to the results of this study LDL-C and total cholesterol were significantly higher in the Q10 group. Although LDL-C significantly increased after 12&#x000a0;weeks of supplementation with Q10, triglyceride and HDL-C decreased after intervention.CoQ10 reduced HDL-C and total cholesterol.</p><p>Our findings confirmed the results of some previous studies on rats and humans. Witting et al. demonstrated that Q10 supplementation had no effect on cholesterol concentration in apolipoprotein E gene knockout mice [<xref ref-type="bibr" rid="B22">22</xref>]. Kunitomo et al. indicated that 6&#x000a0;weeks Q10 treatment had no effect on dyslipidemia in a rat model of metabolic syndrome [<xref ref-type="bibr" rid="B18">18</xref>]. In line with these studies, Chew et al. investigated the effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction (LVDD). The findings of this study showed that daily consumption of 200&#x000a0;mg Q10 does not affect total cholesterol, HDL-C and LDL-C [<xref ref-type="bibr" rid="B20">20</xref>]. These results were similar with the findings of Playford et al. in patients with diabetes [<xref ref-type="bibr" rid="B19">19</xref>]. It has been shown that intake of 40&#x000a0;mg/kg Q10 for 4&#x000a0;weeks significantly reduces the serum levels of triglycerides, total cholesterol, LDL-C and Very Low Density Lipoprotein Cholesterol (VLDL-C) and increases HDL-C in streptozotocin induced diabetic rats [<xref ref-type="bibr" rid="B16">16</xref>]. In general, human studies do not confirm the lipid lowering effects of Q10 in patients with diabetes [<xref ref-type="bibr" rid="B18">18</xref>]-[<xref ref-type="bibr" rid="B20">20</xref>],[<xref ref-type="bibr" rid="B22">22</xref>].</p><p>LDL-C and total cholesterol were significantly higher in the Q10 group compared to the placebo group. Although LDL-C significantly increased after 12&#x000a0;weeks of supplementation with Q10, triglyceride and HDL-C decreased after intervention. There are reports of Q10 supplementation unfavorable effects on lipid profile in certain subgroups of patients such as osteoporotic patients. It is time to ask whether diabetics are among these patients or not?</p><p>According to the results of the present study, after intervention FPG and HbA<sub>1</sub>C were significantly lower in the CoQ10 group compared to the placebo group, but there were no significant changes in glycemic control indices after intervention within the CoQ10 group.</p><p>These findings were in line with many previous published studies. Coenzyme Q10 has been known as an enhancing glycemic control factor acting through several mechanisms, comprising a decrease in oxidative stress [<xref ref-type="bibr" rid="B23">23</xref>],[<xref ref-type="bibr" rid="B24">24</xref>]. Modi et al. showed that administration of Q10 in streptozotocin induced diabetic rats leads to decreasing in serum levels of glucose significantly but serum concentrations of insulin was not changed. HbA<sub>1</sub>C was not measured in their study [<xref ref-type="bibr" rid="B16">16</xref>]. Sena et al. demonstrated that consumption of Q10 supplement reduces HbA<sub>1</sub>C in diabetic rats [<xref ref-type="bibr" rid="B17">17</xref>]. Also, Palyford et al. concluded that CoQ10 significantly decreases HbA1c. Similar with these findings, Hodgson et al. showed that daily intake of 200&#x000a0;mg Q10 in patients with diabetes results in decreasing of HbA1C and consequently long term improvement of glycemic control [<xref ref-type="bibr" rid="B19">19</xref>]. Conversely, the results of a number of published studies revealed no difference in glycemic control and requirement of insulin [<xref ref-type="bibr" rid="B25">25</xref>]-[<xref ref-type="bibr" rid="B27">27</xref>].</p><p>It has been shown that, Q10 levels are reduced in patients with diabetes, and might be responsible for <italic>&#x003b2;</italic> cell depressed function in type 2 diabetes [<xref ref-type="bibr" rid="B28">28</xref>]. Q10 impaired levels may induce insulin resistance via mitochondrial dysfunction [<xref ref-type="bibr" rid="B29">29</xref>].</p><p>There is an increased oxidative stress in patients with diabetes. Hyperglycemia increases ROS formation which activates proteins and pathways such as protein kinase C, polyol, nuclear factor-kappaB and protein kinases (JNK/SAPK).</p><p>Increased functional proteins glycosylation and glucose auto-oxidation are among other responsible mechanisms for ROS production and resulted in lipid peroxidation [<xref ref-type="bibr" rid="B30">30</xref>]. Q10 could enhance fatty acid oxidation through AMPK- mediated (AMP activated protein kinase) peroxisome proliferator-activated receptor &#x003b1; (PRAR&#x003b1;) stimulation [<xref ref-type="bibr" rid="B31">31</xref>] which in turn increases lipoprotein lipase and APO-AV expression. This may decreases TG an VLDL Levels [<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Additionally it has been shown that PRAR&#x003b1; agonist could increase LDL-C size which is more protective against vascular diseases [<xref ref-type="bibr" rid="B33">33</xref>]. PRAR&#x003b1; can inhibit fatty acid and TG synthesis via reduction in SREBP1c and SREBP-2 maturation [<xref ref-type="bibr" rid="B34">34</xref>].</p><p>Antioxidant reserves have been decreased in patients with diabetes. Q10 supplementation may compensate this impaired antioxidant system and decrease oxidative stress in these patients.</p><p>Free fatty acids (FFA) and glucose overload in patients with diabetes tend to increase acetyle-COA production, and increase electron donors from TCA cycle and enhance membrane potential. Increased membrane potential improve free radicals intermediates of Q10 half life that reduces O<sub>2</sub> to superoxide [<xref ref-type="bibr" rid="B35">35</xref>].</p><p>It has been shown that antioxidant treatment may reduce glucose levels [<xref ref-type="bibr" rid="B36">36</xref>] via &#x003b2; cell protection against ROS and glucose toxicity, and increased insulin secretion [<xref ref-type="bibr" rid="B35">35</xref>].</p><p>According to the results of our study HOMA-IR index and insulin levels did not change significantly, however HbA1c levels were significantly decreased. Due to short half-life of insulin, its level does not reflect its mean level in a prolonged period of time. One of the main strength of this study was measurement of Q10 levels before and after intervention.</p><p>There were some limitations in this study. The major limitation was that the inclusion criteria were wide. Also, it would be better if we applied three-day 24- hour recall instead of one-day 24- hour recall to evaluate our patient&#x02019;s diet.</p><p>Proinsulin and C-peptide levels are better markers to show insulin production and &#x003b2; cell function; however these parameters were not measured. Measurement of C-peptide levels would be beneficial, since insulin concentration in the portal vein ranges from two to ten times higher compared to the peripheral circulation. Additionally fasting intact pro insulin could be used as a specific predictor of insulin resistance in type 2 diabetes [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Finally, it should keep in mind that uncontrolled and OTC consumption of any supplement could accompany by several unfavorable and hazardous effects [<xref ref-type="bibr" rid="B38">38</xref>]. In the case of Q10 supplementation for diabetics, lipid profile impairment needs special care.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The results of the present study showed that 12&#x000a0;weeks supplementation with Q10 may improve glycemic control without favorable effects on lipid profiles of patients with diabetes. Further larger studies are warranted to confirm these findings.</p></sec><sec><title>Competing interests</title><p>The authors declare no conflict of interests.</p></sec><sec><title>Authors' contribution</title><p>HZ participated in the statistical analysis, data interpretation and article writing. SE participated in the study design. SS participated in the statistical analysis and data interpretation. NR participated in the study design. FS participated in the study design and data interpretation. IH participated in the data acquisition and interpretation. BG participated in the study design and statistical analysis. SJ participated in the study design, data interpretation, statistical analysis and article writing. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>This work was supported by the Vice-Chancellor for Research, Iran University of Medical Sciences, Tehran, Iran.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Ghorbanihaghjo</surname><given-names>A</given-names></name><name><surname>Kolahi</surname><given-names>S</given-names></name><name><surname>Seifirad</surname><given-names>S</given-names></name><name><surname>Rashtchizadeh</surname><given-names>N</given-names></name><name><surname>Argani</surname><given-names>H</given-names></name><name><surname>Hajialilo</surname><given-names>M</given-names></name><name><surname>Khabazi</surname><given-names>A</given-names></name><name><surname>Alizadeh</surname><given-names>S</given-names></name><name><surname>Bahreini</surname><given-names>E</given-names></name><article-title>Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial</article-title><source>Arch Iran Med</source><year>2012</year><volume>15</volume><fpage>549</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">22924372</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Chew</surname><given-names>G</given-names></name><name><surname>Watts</surname><given-names>G</given-names></name><article-title>Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the &#x02018;recoupling hypothesis&#x02019;</article-title><source>QJM</source><year>2004</year><volume>97</volume><fpage>537</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">15256611</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Rainwater</surname><given-names>DL</given-names></name><name><surname>Mahaney</surname><given-names>MC</given-names></name><name><surname>Stocker</surname><given-names>R</given-names></name><article-title>Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>649</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">15321805</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>SC</given-names></name><name><surname>Lekshminarayanan</surname><given-names>R</given-names></name><name><surname>Goh</surname><given-names>SK</given-names></name><name><surname>Ong</surname><given-names>YY</given-names></name><name><surname>Subramaniam</surname><given-names>T</given-names></name><name><surname>Sum</surname><given-names>CF</given-names></name><name><surname>Ong</surname><given-names>CN</given-names></name><name><surname>Lee</surname><given-names>BL</given-names></name><article-title>The effect of coenzyme Q10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus</article-title><source>Atherosclerosis</source><year>2008</year><volume>196</volume><fpage>966</fpage><lpage>969</lpage><pub-id pub-id-type="pmid">18164307</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Littarru</surname><given-names>GP</given-names></name><name><surname>Tiano</surname><given-names>L</given-names></name><article-title>Bioenergetic and antioxidant properties of coenzyme Q10: recent developments</article-title><source>Mol Biotechnol</source><year>2007</year><volume>37</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">17914161</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Kocharian</surname><given-names>A</given-names></name><name><surname>Shabanian</surname><given-names>R</given-names></name><name><surname>Rafiei-Khorgami</surname><given-names>M</given-names></name><name><surname>Kiani</surname><given-names>A</given-names></name><name><surname>Heidari-Bateni</surname><given-names>G</given-names></name><article-title>Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy</article-title><source>Cardiol Young</source><year>2009</year><volume>19</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">19703336</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Lenaz</surname><given-names>G</given-names></name><name><surname>Fato</surname><given-names>R</given-names></name><name><surname>Castelluccio</surname><given-names>C</given-names></name><name><surname>Cavazzoni</surname><given-names>M</given-names></name><name><surname>Estornell</surname><given-names>E</given-names></name><name><surname>Huertas</surname><given-names>J</given-names></name><name><surname>Pallotti</surname><given-names>F</given-names></name><name><surname>Parenti Castelli</surname><given-names>G</given-names></name><name><surname>Rauchova</surname><given-names>H</given-names></name><article-title>An updating of the biochemical function of coenzyme Q in mitochondria</article-title><source>Mol Aspects Med</source><year>1994</year><volume>15</volume><fpage>s29</fpage><lpage>s36</lpage><pub-id pub-id-type="pmid">7752842</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Bradley</surname><given-names>R</given-names></name><name><surname>Oberg</surname><given-names>EB</given-names></name><name><surname>Calabrese</surname><given-names>C</given-names></name><name><surname>Standish</surname><given-names>LJ</given-names></name><article-title>Algorithm for complementary and alternative medicine practice and research in type 2 diabetes</article-title><source>J Altern Complement Med</source><year>2007</year><volume>13</volume><fpage>159</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">17309390</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Calabrese</surname><given-names>V</given-names></name><name><surname>Lodi</surname><given-names>R</given-names></name><name><surname>Tonon</surname><given-names>C</given-names></name><name><surname>D'Agata</surname><given-names>V</given-names></name><name><surname>Sapienza</surname><given-names>M</given-names></name><name><surname>Scapagnini</surname><given-names>G</given-names></name><name><surname>Mangiameli</surname><given-names>A</given-names></name><name><surname>Pennisi</surname><given-names>G</given-names></name><name><surname>Stella</surname><given-names>A</given-names></name><name><surname>Butterfield</surname><given-names>DA</given-names></name><article-title>Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia</article-title><source>J Neurol Sci</source><year>2005</year><volume>233</volume><fpage>145</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">15896810</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Emerit</surname><given-names>J</given-names></name><name><surname>Edeas</surname><given-names>M</given-names></name><name><surname>Bricaire</surname><given-names>F</given-names></name><article-title>Neurodegenerative diseases and oxidative stress</article-title><source>Biomed Pharmacother</source><year>2004</year><volume>58</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">14739060</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Bliznakov</surname><given-names>EG</given-names></name><article-title>Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case&#x02013;a modern Pandora's box</article-title><source>Biomed Pharmacother</source><year>2002</year><volume>56</volume><fpage>56</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">11905511</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Lamson</surname><given-names>DW</given-names></name><name><surname>Plaza</surname><given-names>SM</given-names></name><article-title>Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment</article-title><source>Altern Med Rev</source><year>2002</year><volume>7</volume><fpage>94</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">11991790</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Salles</surname><given-names>JE</given-names></name><name><surname>Mois&#x000e9;s</surname><given-names>VA</given-names></name><name><surname>Almeida</surname><given-names>DR</given-names></name><name><surname>Chacra</surname><given-names>AR</given-names></name><name><surname>Mois&#x000e9;s</surname><given-names>RS</given-names></name><article-title>Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10</article-title><source>Diabetes Res Clin Pract</source><year>2006</year><volume>72</volume><fpage>100</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">16253379</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Hinokio</surname><given-names>Y</given-names></name><name><surname>Ohtomo</surname><given-names>M</given-names></name><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Hirai</surname><given-names>A</given-names></name><name><surname>Chiba</surname><given-names>M</given-names></name><name><surname>Kasuga</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>Y</given-names></name><name><surname>Akai</surname><given-names>H</given-names></name><name><surname>Toyota</surname><given-names>T</given-names></name><article-title>The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation</article-title><source>Diabetologia</source><year>1998</year><volume>41</volume><fpage>584</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">9628277</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Goh</surname><given-names>S</given-names></name><name><surname>Subramaniam</surname><given-names>T</given-names></name><name><surname>Sum</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Ong</surname><given-names>C</given-names></name><article-title>Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q10</article-title><source>Diabet Med</source><year>2006</year><volume>23</volume><fpage>1344</fpage><lpage>1349</lpage><pub-id pub-id-type="pmid">17116186</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Modi</surname><given-names>K</given-names></name><name><surname>Santani</surname><given-names>D</given-names></name><name><surname>Goyal</surname><given-names>R</given-names></name><name><surname>Bhatt</surname><given-names>P</given-names></name><article-title>Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats</article-title><source>Biol Trace Elem Res</source><year>2006</year><volume>109</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">16388100</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Sena</surname><given-names>CM</given-names></name><name><surname>Nunes</surname><given-names>E</given-names></name><name><surname>Gomes</surname><given-names>A</given-names></name><name><surname>Santos</surname><given-names>MS</given-names></name><name><surname>Proenca</surname><given-names>T</given-names></name><name><surname>Martins</surname><given-names>MI</given-names></name><name><surname>Seica</surname><given-names>RM</given-names></name><article-title>Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats</article-title><source>Nutr Res</source><year>2008</year><volume>28</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">19083397</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Kunitomo</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Kagota</surname><given-names>S</given-names></name><name><surname>Otsubo</surname><given-names>K</given-names></name><article-title>Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome</article-title><source>J Pharmacol Sci</source><year>2008</year><volume>107</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">18544898</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Playford</surname><given-names>DA</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name><name><surname>Croft</surname><given-names>KD</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><article-title>Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes</article-title><source>Atherosclerosis</source><year>2003</year><volume>168</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">12732401</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Chew</surname><given-names>GT</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name><name><surname>Davis</surname><given-names>TM</given-names></name><name><surname>Stuckey</surname><given-names>BG</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Thompson</surname><given-names>PL</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Currie</surname><given-names>PJ</given-names></name><article-title>Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><fpage>1502</fpage><lpage>1509</lpage><pub-id pub-id-type="pmid">18487480</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Hodgson</surname><given-names>JM</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name><name><surname>Playford</surname><given-names>DA</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Croft</surname><given-names>KD</given-names></name><article-title>Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes</article-title><source>Eur J Clin Nutr</source><year>2002</year><volume>56</volume><fpage>1137</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">12428181</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Witting</surname><given-names>PK</given-names></name><name><surname>Pettersson</surname><given-names>K</given-names></name><name><surname>Letters</surname><given-names>J</given-names></name><name><surname>Stocker</surname><given-names>R</given-names></name><article-title>Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice</article-title><source>Free Radic Biol Med</source><year>2000</year><volume>29</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">11035258</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Littarru</surname><given-names>GP</given-names></name><name><surname>Tiano</surname><given-names>L</given-names></name><article-title>Clinical aspects of coenzyme Q10: an update</article-title><source>Nutrition</source><year>2010</year><volume>26</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">19932599</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Quiles</surname><given-names>JL</given-names></name><name><surname>Ochoa</surname><given-names>JJ</given-names></name><name><surname>Battino</surname><given-names>M</given-names></name><name><surname>Gutierrez-Rios</surname><given-names>P</given-names></name><name><surname>Nepomuceno</surname><given-names>EA</given-names></name><name><surname>Frias</surname><given-names>ML</given-names></name><name><surname>Huertas</surname><given-names>JR</given-names></name><name><surname>Mataix</surname><given-names>J</given-names></name><article-title>Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage</article-title><source>Biofactors</source><year>2005</year><volume>25</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16873932</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Forsen</surname><given-names>TJ</given-names></name><name><surname>Mortensen</surname><given-names>SA</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><article-title>The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus</article-title><source>Biofactors</source><year>1999</year><volume>9</volume><fpage>315</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">10416046</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Henriksen</surname><given-names>JE</given-names></name><name><surname>Andersen</surname><given-names>CB</given-names></name><name><surname>Hother-Nielsen</surname><given-names>O</given-names></name><name><surname>Vaag</surname><given-names>A</given-names></name><name><surname>Mortensen</surname><given-names>SA</given-names></name><name><surname>Beck-Nielsen</surname><given-names>H</given-names></name><article-title>Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus</article-title><source>Diabet Med</source><year>1999</year><volume>16</volume><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">10220205</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Coldiron</surname><given-names>AD</given-names><suffix>Jr</suffix></name><name><surname>Sanders</surname><given-names>RA</given-names></name><name><surname>Watkins</surname><given-names>JB</given-names><suffix>3rd</suffix></name><article-title>Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats</article-title><source>J Biochem Mol Toxicol</source><year>2002</year><volume>16</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">12242689</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AA</given-names></name><article-title>Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus</article-title><source>Endocrinol Metab Clin North Am</source><year>2001</year><volume>30</volume><fpage>983</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">11727407</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Petersen</surname><given-names>KF</given-names></name><name><surname>Befroy</surname><given-names>D</given-names></name><name><surname>Dufour</surname><given-names>S</given-names></name><name><surname>Dziura</surname><given-names>J</given-names></name><name><surname>Ariyan</surname><given-names>C</given-names></name><name><surname>Rothman</surname><given-names>DL</given-names></name><name><surname>DiPietro</surname><given-names>L</given-names></name><name><surname>Cline</surname><given-names>GW</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name><article-title>Mitochondrial dysfunction in the elderly: possible role in insulin resistance</article-title><source>Science</source><year>2003</year><volume>300</volume><fpage>1140</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">12750520</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Fagot-Campagna</surname><given-names>A</given-names></name><name><surname>Pettitt</surname><given-names>DJ</given-names></name><name><surname>Engelgau</surname><given-names>MM</given-names></name><name><surname>Burrows</surname><given-names>NR</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name><name><surname>Valdez</surname><given-names>R</given-names></name><name><surname>Beckles</surname><given-names>GL</given-names></name><name><surname>Saaddine</surname><given-names>J</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Williamson</surname><given-names>DF</given-names></name><article-title>Type 2 diabetes among North adolescents: An epidemiologic health perspective</article-title><source>J Pediatr</source><year>2000</year><volume>136</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">10802501</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>You</surname><given-names>GY</given-names></name><name><surname>Moon</surname><given-names>JW</given-names></name><name><surname>Sha</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>YW</given-names></name><name><surname>Kang</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><article-title>Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARalpha induction in 3&#x000a0;T3-L1 preadipocytes</article-title><source>Cell Signal</source><year>2012</year><volume>24</volume><fpage>2329</fpage><lpage>2336</lpage><pub-id pub-id-type="pmid">22885103</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Suckling</surname><given-names>KE</given-names></name><name><surname>Jackson</surname><given-names>B</given-names></name><article-title>Animal models of human lipid metabolism</article-title><source>Prog Lipid Res</source><year>1993</year><volume>32</volume><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8415795</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Ruotolo</surname><given-names>G</given-names></name><name><surname>Ericsson</surname><given-names>CG</given-names></name><name><surname>Tettamanti</surname><given-names>C</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Grip</surname><given-names>L</given-names></name><name><surname>Svane</surname><given-names>B</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><article-title>Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)</article-title><source>J Am Coll Cardiol</source><year>1998</year><volume>32</volume><fpage>1648</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">9822092</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Klopotek</surname><given-names>A</given-names></name><name><surname>Hirche</surname><given-names>F</given-names></name><name><surname>Eder</surname><given-names>K</given-names></name><article-title>PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2</article-title><source>Exp Biol Med (Maywood)</source><year>2006</year><volume>231</volume><fpage>1365</fpage><lpage>1372</lpage><pub-id pub-id-type="pmid">16946405</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Schroeder</surname><given-names>MM</given-names></name><name><surname>Belloto</surname><given-names>RJ</given-names><suffix>Jr</suffix></name><name><surname>Hudson</surname><given-names>RA</given-names></name><name><surname>McInerney</surname><given-names>MF</given-names></name><article-title>Effects of antioxidants coenzyme Q10 and lipoic acid on interleukin-1 beta-mediated inhibition of glucose-stimulated insulin release from cultured mouse pancreatic islets</article-title><source>Immunopharmacol Immunotoxicol</source><year>2005</year><volume>27</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">15803864</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Kajimoto</surname><given-names>Y</given-names></name><name><surname>Kaneto</surname><given-names>H</given-names></name><article-title>Role of oxidative stress in pancreatic beta-cell dysfunction</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1011</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">15126294</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Pfutzner</surname><given-names>A</given-names></name><name><surname>Kunt</surname><given-names>T</given-names></name><name><surname>Hohberg</surname><given-names>C</given-names></name><name><surname>Mondok</surname><given-names>A</given-names></name><name><surname>Pahler</surname><given-names>S</given-names></name><name><surname>Konrad</surname><given-names>T</given-names></name><name><surname>Lubben</surname><given-names>G</given-names></name><name><surname>Forst</surname><given-names>T</given-names></name><article-title>Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">14988285</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Seifirad</surname><given-names>S</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Amoli</surname><given-names>MM</given-names></name><article-title>The antioxidants dilemma: are they potentially immunosuppressants and carcinogens?</article-title><source>Front. Physiol</source><year>2014</year><volume>5</volume><fpage>245</fpage><comment>doi:10.3389/fphys.2014.00245</comment><pub-id pub-id-type="pmid">25071590</pub-id></mixed-citation></ref></ref-list></back></article>